Anavex Life Sciences Corp (NASDAQ:AVXL)

9.18
Delayed Data
As of Sep 23
 -0.16 / -1.71%
Today’s Change
7.13
Today|||52-Week Range
23.73
-47.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash15.3M9.2M27.4M22.9M
 
 
 
 
 
Short Term Investment Cash8.0M-6.1M18.3M-4.5M
 
 
 
 
 
Cash & Short Term Investments15.3M9.2M27.4M22.9M
 
 
 
 
 
 
ReceivablesReceivables76.8K79.3K9.7K40.2K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses100.8K180.1K335.9K1.3M
 
 
 
 
 
Current Assets15.5M9.4M27.8M24.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.0K------
 
 
Depreciation-1.8K------
 
 
Other Assets0.0052.4K52.4K153.5K
 
 
 
 
Total Assets15.5M9.5M27.8M24.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.000.003.6M3.9M
 
 
 
Short Term Debt85.2K0.000.000.00
 
 
Accrued Expenses2.5M3.1M----
 
 
 
Other Current Liabilities2.6M3.2M0.000.00
 
 
 
Other Liabilities2.7M3.2M3.6M3.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt332.000.000.000.00
 
 
Total Liabilities2.7M3.2M3.6M3.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity12.8M6.3M24.3M20.5M
 
 
 
 
 
Total Shareholder Equity12.8M6.3M24.3M20.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding32.0M36.2M43.3M45.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.